Actual Medicinal Product (AMP) Diltiazem 300mg modified-release capsules (A A H Pharmaceuticals Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Light sensitive medicine. Store in light resistant container. Moisture sensitive medicine. Store in airtight (sealed) MCA. Manufacturer recommends storing in original container.
Anecdotal reports of use in MCAs for up to 7 days (low quality evidence). - Provenance
-
This recommendation is based on the products and Adizem-XL 300mg capsules (Napp Pharmaceuticals Limited), Zemtard 300mg prolonged-release capsules (Galen Limited) and Viazem XL 300mg (Thornton & Ross Ltd).
- Generic
- Diltiazem
- Formulation
- Diltiazem 300mg modified-release capsules
-
Diltiazem
-
Diltiazem 300mg modified-release capsules
-
Diltiazem 300mg modified-release capsules (A A H Pharmaceuticals Ltd)
-
-
Diltiazem 60mg modified-release capsules